An international phase IIB trial of a new experimental medication, known as MIS416, for secondary progressive MS has successfully completed recruitment. The trial commenced in September 2014 and [...]
1300 010 email@example.com
We're not around right now. But you can send us an email and we'll get back to you, asap.
Start typing and press Enter to search